Giant	B:C0039483
cell	I:C0039483
arteritis	I:C0039483
and	O
vascular	O
disease	I:C2584745
-	I:C2584745
risk	I:C2584745
factors	I:C2584745
and	O
outcomes	O
:	O
a	O
cohort	O
study	O
using	O
UK	O
Clinical	O
Practice	I:C0282451
Research	I:C0282451
Datalink	I:C0282451

Giant	O
cell	I:C0039483
arteritis	I:C0039483
and	O
vascular	B:C2584745
disease	I:C2584745
-	I:C2584745
risk	I:C2584745
factors	I:C2584745
and	O
outcomes	O
:	O
a	O
cohort	O
study	O
using	O
UK	O
Clinical	O
Practice	I:C0282451
Research	I:C0282451
Datalink	I:C0282451

Giant	O
cell	I:C0039483
arteritis	I:C0039483
and	O
vascular	O
disease	I:C2584745
-	I:C2584745
risk	I:C2584745
factors	I:C2584745
and	O
outcomes	B:C0543472
:	O
a	O
cohort	O
study	O
using	O
UK	O
Clinical	O
Practice	I:C0282451
Research	I:C0282451
Datalink	I:C0282451

Giant	O
cell	I:C0039483
arteritis	I:C0039483
and	O
vascular	O
disease	I:C2584745
-	I:C2584745
risk	I:C2584745
factors	I:C2584745
and	O
outcomes	O
:	O
a	O
cohort	O
study	O
using	O
UK	B:C0041700
Clinical	O
Practice	I:C0282451
Research	I:C0282451
Datalink	I:C0282451

Giant	O
cell	I:C0039483
arteritis	I:C0039483
and	O
vascular	O
disease	I:C2584745
-	I:C2584745
risk	I:C2584745
factors	I:C2584745
and	O
outcomes	O
:	O
a	O
cohort	O
study	O
using	O
UK	O
Clinical	B:C0282451
Practice	I:C0282451
Research	I:C0282451
Datalink	I:C0282451

To	B:C0220825
evaluate	I:C0220825
the	O
associations	O
between	O
GCA	O
and	O
vascular	O
diseases	I:C0042373
and	O
other	O
comorbidities	O
in	O
patients	O
with	O
GCA	O
compared	O
with	O
non-vasculitis	O
patients	O
.	O

To	O
evaluate	I:C0220825
the	O
associations	O
between	O
GCA	B:C0039483
and	O
vascular	O
diseases	I:C0042373
and	O
other	O
comorbidities	O
in	O
patients	O
with	O
GCA	O
compared	O
with	O
non-vasculitis	O
patients	O
.	O

To	O
evaluate	I:C0220825
the	O
associations	O
between	O
GCA	O
and	O
vascular	B:C0042373
diseases	I:C0042373
and	O
other	O
comorbidities	O
in	O
patients	O
with	O
GCA	O
compared	O
with	O
non-vasculitis	O
patients	O
.	O

To	O
evaluate	I:C0220825
the	O
associations	O
between	O
GCA	O
and	O
vascular	O
diseases	I:C0042373
and	O
other	O
comorbidities	O
in	O
patients	O
with	O
GCA	B:C0039483
compared	O
with	O
non-vasculitis	O
patients	O
.	O

Using	O
the	O
UK	B:C0041700
-	I:C0041700
based	I:C0041700
Clinical	O
Practice	I:C0282451
Research	I:C0282451
Datalink	I:C0282451
we	O
identified	O
9778	O
newly	O
diagnosed	O
GCA	O
patients	O
in	O
1990	O
-	O
2014	O
,	O
and	O
up	O
to	O
10	O
non-vasculitis	O
patients	O
randomly	O
matched	I:C0034656
to	O
each	O
case	O
on	O
age	O
,	O
sex	O
,	O
practice	O
and	O
years	O
of	I:C2004062
history	I:C2004062
before	O
cohort	O
entry	O
.	O

Using	O
the	O
UK	O
-	I:C0041700
based	I:C0041700
Clinical	B:C0282451
Practice	I:C0282451
Research	I:C0282451
Datalink	I:C0282451
we	O
identified	O
9778	O
newly	O
diagnosed	O
GCA	O
patients	O
in	O
1990	O
-	O
2014	O
,	O
and	O
up	O
to	O
10	O
non-vasculitis	O
patients	O
randomly	O
matched	I:C0034656
to	O
each	O
case	O
on	O
age	O
,	O
sex	O
,	O
practice	O
and	O
years	O
of	I:C2004062
history	I:C2004062
before	O
cohort	O
entry	O
.	O

Using	O
the	O
UK	O
-	I:C0041700
based	I:C0041700
Clinical	O
Practice	I:C0282451
Research	I:C0282451
Datalink	I:C0282451
we	O
identified	O
9778	O
newly	O
diagnosed	O
GCA	B:C0039483
patients	O
in	O
1990	O
-	O
2014	O
,	O
and	O
up	O
to	O
10	O
non-vasculitis	O
patients	O
randomly	O
matched	I:C0034656
to	O
each	O
case	O
on	O
age	O
,	O
sex	O
,	O
practice	O
and	O
years	O
of	I:C2004062
history	I:C2004062
before	O
cohort	O
entry	O
.	O

Using	O
the	O
UK	O
-	I:C0041700
based	I:C0041700
Clinical	O
Practice	I:C0282451
Research	I:C0282451
Datalink	I:C0282451
we	O
identified	O
9778	O
newly	O
diagnosed	O
GCA	O
patients	O
in	O
1990	O
-	O
2014	O
,	O
and	O
up	O
to	O
10	O
non-vasculitis	O
patients	O
randomly	B:C0034656
matched	I:C0034656
to	O
each	O
case	O
on	O
age	O
,	O
sex	O
,	O
practice	O
and	O
years	O
of	I:C2004062
history	I:C2004062
before	O
cohort	O
entry	O
.	O

Using	O
the	O
UK	O
-	I:C0041700
based	I:C0041700
Clinical	O
Practice	I:C0282451
Research	I:C0282451
Datalink	I:C0282451
we	O
identified	O
9778	O
newly	O
diagnosed	O
GCA	O
patients	O
in	O
1990	O
-	O
2014	O
,	O
and	O
up	O
to	O
10	O
non-vasculitis	O
patients	O
randomly	O
matched	I:C0034656
to	O
each	O
case	O
on	O
age	O
,	O
sex	O
,	O
practice	B:C0237607
and	O
years	O
of	I:C2004062
history	I:C2004062
before	O
cohort	O
entry	O
.	O

Using	O
the	O
UK	O
-	I:C0041700
based	I:C0041700
Clinical	O
Practice	I:C0282451
Research	I:C0282451
Datalink	I:C0282451
we	O
identified	O
9778	O
newly	O
diagnosed	O
GCA	O
patients	O
in	O
1990	O
-	O
2014	O
,	O
and	O
up	O
to	O
10	O
non-vasculitis	O
patients	O
randomly	O
matched	I:C0034656
to	O
each	O
case	O
on	O
age	O
,	O
sex	O
,	O
practice	O
and	O
years	B:C2004062
of	I:C2004062
history	I:C2004062
before	O
cohort	O
entry	O
.	O

We	O
compared	O
the	O
distributions	O
of	O
9	O
different	O
pre-existing	O
vascular	B:C0042373
diseases	I:C0042373
and	O
11	O
other	O
comorbidities	O
,	O
and	O
risks	O
of	O
incident	O
vascular	O
diseases	I:C0042373
and	O
other	O
comorbidities	O
after	O
cohort	O
entry	O
between	O
GCA	O
and	O
non-vasculitis	O
patients	O
.	O

We	O
compared	O
the	O
distributions	O
of	O
9	O
different	O
pre-existing	O
vascular	O
diseases	I:C0042373
and	O
11	O
other	O
comorbidities	O
,	O
and	O
risks	O
of	O
incident	O
vascular	B:C0042373
diseases	I:C0042373
and	O
other	O
comorbidities	O
after	O
cohort	O
entry	O
between	O
GCA	O
and	O
non-vasculitis	O
patients	O
.	O

We	O
compared	O
the	O
distributions	O
of	O
9	O
different	O
pre-existing	O
vascular	O
diseases	I:C0042373
and	O
11	O
other	O
comorbidities	O
,	O
and	O
risks	O
of	O
incident	O
vascular	O
diseases	I:C0042373
and	O
other	O
comorbidities	O
after	O
cohort	O
entry	O
between	O
GCA	B:C0039483
and	O
non-vasculitis	O
patients	O
.	O

Patients	O
with	O
GCA	B:C0039483
were	O
more	O
likely	O
to	O
have	O
a	O
history	O
of	O
vascular	O
diseases	I:C0042373
and	O
other	O
comorbidities	O
except	O
myocardial	O
infarction	I:C0027051
,	O
type	O
2	I:C0011860
diabetes	I:C0011860
,	O
obesity	O
and	O
cancer	O
,	O
compared	O
with	O
non-vasculitis	O
patients	O
.	O

Patients	O
with	O
GCA	O
were	O
more	O
likely	O
to	O
have	O
a	O
history	O
of	O
vascular	B:C0042373
diseases	I:C0042373
and	O
other	O
comorbidities	O
except	O
myocardial	O
infarction	I:C0027051
,	O
type	O
2	I:C0011860
diabetes	I:C0011860
,	O
obesity	O
and	O
cancer	O
,	O
compared	O
with	O
non-vasculitis	O
patients	O
.	O

Patients	O
with	O
GCA	O
were	O
more	O
likely	O
to	O
have	O
a	O
history	O
of	O
vascular	O
diseases	I:C0042373
and	O
other	O
comorbidities	O
except	O
myocardial	B:C0027051
infarction	I:C0027051
,	O
type	O
2	I:C0011860
diabetes	I:C0011860
,	O
obesity	O
and	O
cancer	O
,	O
compared	O
with	O
non-vasculitis	O
patients	O
.	O

Patients	O
with	O
GCA	O
were	O
more	O
likely	O
to	O
have	O
a	O
history	O
of	O
vascular	O
diseases	I:C0042373
and	O
other	O
comorbidities	O
except	O
myocardial	O
infarction	I:C0027051
,	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
,	O
obesity	O
and	O
cancer	O
,	O
compared	O
with	O
non-vasculitis	O
patients	O
.	O

Patients	O
with	O
GCA	O
were	O
more	O
likely	O
to	O
have	O
a	O
history	O
of	O
vascular	O
diseases	I:C0042373
and	O
other	O
comorbidities	O
except	O
myocardial	O
infarction	I:C0027051
,	O
type	O
2	I:C0011860
diabetes	I:C0011860
,	O
obesity	B:C0028754
and	O
cancer	O
,	O
compared	O
with	O
non-vasculitis	O
patients	O
.	O

Patients	O
with	O
GCA	O
were	O
more	O
likely	O
to	O
have	O
a	O
history	O
of	O
vascular	O
diseases	I:C0042373
and	O
other	O
comorbidities	O
except	O
myocardial	O
infarction	I:C0027051
,	O
type	O
2	I:C0011860
diabetes	I:C0011860
,	O
obesity	O
and	O
cancer	B:C0006826
,	O
compared	O
with	O
non-vasculitis	O
patients	O
.	O

Patients	O
with	O
GCA	B:C0039483
had	O
increased	O
risks	O
for	I:C0580320
all	I:C0580320
types	I:C0580320
of	I:C0580320
incident	I:C0580320
vascular	O
disease	I:C0042373
compared	O
with	O
non-vasculitis	O
patients	O
:	O
adjusted	O
hazard	O
ratios	O
were	O
1.57	O
(	O
95	O
%	O
CI	O
:	O
1.36	O
,	O
1.82	O
)	O
for	O
myocardial	O
infarction	I:C0027051
,	O
1.41	O
(	O
95	O
%	O
CI	O
:	O
1.29	O
,	O
1.55	O
)	O
for	O
stroke	O
,	O
1.75	O
(	O
95	O
%	O
CI	O
:	O
1.49	O
,	O
2.06	O
)	O
for	O
peripheral	O
vascular	I:C0085096
disease	I:C0085096
,	O
1.98	O
(	O
95	O
%	O
CI	O
:	O
1.50	O
,	O
2.62	O
)	O
for	O
aortic	O
aneurysm	I:C0003486
and	O
2.03	O
(	O
95	O
%	O
CI	O
:	O
1.77	O
,	O
2.33	O
)	O
for	O
venous	O
thromboembolism	I:C1861172
.	O

Patients	O
with	O
GCA	O
had	O
increased	O
risks	B:C0580320
for	I:C0580320
all	I:C0580320
types	I:C0580320
of	I:C0580320
incident	I:C0580320
vascular	O
disease	I:C0042373
compared	O
with	O
non-vasculitis	O
patients	O
:	O
adjusted	O
hazard	O
ratios	O
were	O
1.57	O
(	O
95	O
%	O
CI	O
:	O
1.36	O
,	O
1.82	O
)	O
for	O
myocardial	O
infarction	I:C0027051
,	O
1.41	O
(	O
95	O
%	O
CI	O
:	O
1.29	O
,	O
1.55	O
)	O
for	O
stroke	O
,	O
1.75	O
(	O
95	O
%	O
CI	O
:	O
1.49	O
,	O
2.06	O
)	O
for	O
peripheral	O
vascular	I:C0085096
disease	I:C0085096
,	O
1.98	O
(	O
95	O
%	O
CI	O
:	O
1.50	O
,	O
2.62	O
)	O
for	O
aortic	O
aneurysm	I:C0003486
and	O
2.03	O
(	O
95	O
%	O
CI	O
:	O
1.77	O
,	O
2.33	O
)	O
for	O
venous	O
thromboembolism	I:C1861172
.	O

Patients	O
with	O
GCA	O
had	O
increased	O
risks	O
for	I:C0580320
all	I:C0580320
types	I:C0580320
of	I:C0580320
incident	I:C0580320
vascular	B:C0042373
disease	I:C0042373
compared	O
with	O
non-vasculitis	O
patients	O
:	O
adjusted	O
hazard	O
ratios	O
were	O
1.57	O
(	O
95	O
%	O
CI	O
:	O
1.36	O
,	O
1.82	O
)	O
for	O
myocardial	O
infarction	I:C0027051
,	O
1.41	O
(	O
95	O
%	O
CI	O
:	O
1.29	O
,	O
1.55	O
)	O
for	O
stroke	O
,	O
1.75	O
(	O
95	O
%	O
CI	O
:	O
1.49	O
,	O
2.06	O
)	O
for	O
peripheral	O
vascular	I:C0085096
disease	I:C0085096
,	O
1.98	O
(	O
95	O
%	O
CI	O
:	O
1.50	O
,	O
2.62	O
)	O
for	O
aortic	O
aneurysm	I:C0003486
and	O
2.03	O
(	O
95	O
%	O
CI	O
:	O
1.77	O
,	O
2.33	O
)	O
for	O
venous	O
thromboembolism	I:C1861172
.	O

Patients	O
with	O
GCA	O
had	O
increased	O
risks	O
for	I:C0580320
all	I:C0580320
types	I:C0580320
of	I:C0580320
incident	I:C0580320
vascular	O
disease	I:C0042373
compared	O
with	O
non-vasculitis	O
patients	O
:	O
adjusted	O
hazard	O
ratios	O
were	O
1.57	O
(	O
95	O
%	O
CI	O
:	O
1.36	O
,	O
1.82	O
)	O
for	O
myocardial	B:C0027051
infarction	I:C0027051
,	O
1.41	O
(	O
95	O
%	O
CI	O
:	O
1.29	O
,	O
1.55	O
)	O
for	O
stroke	O
,	O
1.75	O
(	O
95	O
%	O
CI	O
:	O
1.49	O
,	O
2.06	O
)	O
for	O
peripheral	O
vascular	I:C0085096
disease	I:C0085096
,	O
1.98	O
(	O
95	O
%	O
CI	O
:	O
1.50	O
,	O
2.62	O
)	O
for	O
aortic	O
aneurysm	I:C0003486
and	O
2.03	O
(	O
95	O
%	O
CI	O
:	O
1.77	O
,	O
2.33	O
)	O
for	O
venous	O
thromboembolism	I:C1861172
.	O

Patients	O
with	O
GCA	O
had	O
increased	O
risks	O
for	I:C0580320
all	I:C0580320
types	I:C0580320
of	I:C0580320
incident	I:C0580320
vascular	O
disease	I:C0042373
compared	O
with	O
non-vasculitis	O
patients	O
:	O
adjusted	O
hazard	O
ratios	O
were	O
1.57	O
(	O
95	O
%	O
CI	O
:	O
1.36	O
,	O
1.82	O
)	O
for	O
myocardial	O
infarction	I:C0027051
,	O
1.41	O
(	O
95	O
%	O
CI	O
:	O
1.29	O
,	O
1.55	O
)	O
for	O
stroke	B:C0038454
,	O
1.75	O
(	O
95	O
%	O
CI	O
:	O
1.49	O
,	O
2.06	O
)	O
for	O
peripheral	O
vascular	I:C0085096
disease	I:C0085096
,	O
1.98	O
(	O
95	O
%	O
CI	O
:	O
1.50	O
,	O
2.62	O
)	O
for	O
aortic	O
aneurysm	I:C0003486
and	O
2.03	O
(	O
95	O
%	O
CI	O
:	O
1.77	O
,	O
2.33	O
)	O
for	O
venous	O
thromboembolism	I:C1861172
.	O

Patients	O
with	O
GCA	O
had	O
increased	O
risks	O
for	I:C0580320
all	I:C0580320
types	I:C0580320
of	I:C0580320
incident	I:C0580320
vascular	O
disease	I:C0042373
compared	O
with	O
non-vasculitis	O
patients	O
:	O
adjusted	O
hazard	O
ratios	O
were	O
1.57	O
(	O
95	O
%	O
CI	O
:	O
1.36	O
,	O
1.82	O
)	O
for	O
myocardial	O
infarction	I:C0027051
,	O
1.41	O
(	O
95	O
%	O
CI	O
:	O
1.29	O
,	O
1.55	O
)	O
for	O
stroke	O
,	O
1.75	O
(	O
95	O
%	O
CI	O
:	O
1.49	O
,	O
2.06	O
)	O
for	O
peripheral	B:C0085096
vascular	I:C0085096
disease	I:C0085096
,	O
1.98	O
(	O
95	O
%	O
CI	O
:	O
1.50	O
,	O
2.62	O
)	O
for	O
aortic	O
aneurysm	I:C0003486
and	O
2.03	O
(	O
95	O
%	O
CI	O
:	O
1.77	O
,	O
2.33	O
)	O
for	O
venous	O
thromboembolism	I:C1861172
.	O

Patients	O
with	O
GCA	O
had	O
increased	O
risks	O
for	I:C0580320
all	I:C0580320
types	I:C0580320
of	I:C0580320
incident	I:C0580320
vascular	O
disease	I:C0042373
compared	O
with	O
non-vasculitis	O
patients	O
:	O
adjusted	O
hazard	O
ratios	O
were	O
1.57	O
(	O
95	O
%	O
CI	O
:	O
1.36	O
,	O
1.82	O
)	O
for	O
myocardial	O
infarction	I:C0027051
,	O
1.41	O
(	O
95	O
%	O
CI	O
:	O
1.29	O
,	O
1.55	O
)	O
for	O
stroke	O
,	O
1.75	O
(	O
95	O
%	O
CI	O
:	O
1.49	O
,	O
2.06	O
)	O
for	O
peripheral	O
vascular	I:C0085096
disease	I:C0085096
,	O
1.98	O
(	O
95	O
%	O
CI	O
:	O
1.50	O
,	O
2.62	O
)	O
for	O
aortic	B:C0003486
aneurysm	I:C0003486
and	O
2.03	O
(	O
95	O
%	O
CI	O
:	O
1.77	O
,	O
2.33	O
)	O
for	O
venous	O
thromboembolism	I:C1861172
.	O

Patients	O
with	O
GCA	O
had	O
increased	O
risks	O
for	I:C0580320
all	I:C0580320
types	I:C0580320
of	I:C0580320
incident	I:C0580320
vascular	O
disease	I:C0042373
compared	O
with	O
non-vasculitis	O
patients	O
:	O
adjusted	O
hazard	O
ratios	O
were	O
1.57	O
(	O
95	O
%	O
CI	O
:	O
1.36	O
,	O
1.82	O
)	O
for	O
myocardial	O
infarction	I:C0027051
,	O
1.41	O
(	O
95	O
%	O
CI	O
:	O
1.29	O
,	O
1.55	O
)	O
for	O
stroke	O
,	O
1.75	O
(	O
95	O
%	O
CI	O
:	O
1.49	O
,	O
2.06	O
)	O
for	O
peripheral	O
vascular	I:C0085096
disease	I:C0085096
,	O
1.98	O
(	O
95	O
%	O
CI	O
:	O
1.50	O
,	O
2.62	O
)	O
for	O
aortic	O
aneurysm	I:C0003486
and	O
2.03	O
(	O
95	O
%	O
CI	O
:	O
1.77	O
,	O
2.33	O
)	O
for	O
venous	B:C1861172
thromboembolism	I:C1861172
.	O

Patients	O
with	O
GCA	B:C0039483
also	O
had	O
increased	O
risks	O
for	I:C1281905
other	I:C1281905
incident	I:C1281905
comorbidities	O
(	O
type	O
2	I:C0011860
diabetes	I:C0011860
,	O
depression	O
,	O
etc.	O
)	O
,	O
but	O
not	O
for	O
cancer	O
.	O

Patients	O
with	O
GCA	O
also	O
had	O
increased	O
risks	B:C1281905
for	I:C1281905
other	I:C1281905
incident	I:C1281905
comorbidities	O
(	O
type	O
2	I:C0011860
diabetes	I:C0011860
,	O
depression	O
,	O
etc.	O
)	O
,	O
but	O
not	O
for	O
cancer	O
.	O

Patients	O
with	O
GCA	O
also	O
had	O
increased	O
risks	O
for	I:C1281905
other	I:C1281905
incident	I:C1281905
comorbidities	O
(	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
,	O
depression	O
,	O
etc.	O
)	O
,	O
but	O
not	O
for	O
cancer	O
.	O

Patients	O
with	O
GCA	O
also	O
had	O
increased	O
risks	O
for	I:C1281905
other	I:C1281905
incident	I:C1281905
comorbidities	O
(	O
type	O
2	I:C0011860
diabetes	I:C0011860
,	O
depression	B:C0011570
,	O
etc.	O
)	O
,	O
but	O
not	O
for	O
cancer	O
.	O

Patients	O
with	O
GCA	O
also	O
had	O
increased	O
risks	O
for	I:C1281905
other	I:C1281905
incident	I:C1281905
comorbidities	O
(	O
type	O
2	I:C0011860
diabetes	I:C0011860
,	O
depression	O
,	O
etc.	O
)	O
,	O
but	O
not	O
for	O
cancer	B:C0006826
.	O

Patients	O
with	O
GCA	B:C0039483
had	O
more	O
prior	O
vascular	O
diseases	I:C0042373
and	O
other	O
comorbidities	O
before	O
the	O
diagnosis	O
and	O
they	O
also	O
had	O
increased	O
risks	O
for	I:C1281905
incident	I:C1281905
vascular	O
diseases	I:C0042373
and	O
many	O
other	O
incident	O
comorbidities	O
after	O
the	O
diagnosis	O
compared	O
with	O
non-vasculitis	O
population	O
.	O

Patients	O
with	O
GCA	O
had	O
more	O
prior	O
vascular	B:C0042373
diseases	I:C0042373
and	O
other	O
comorbidities	O
before	O
the	O
diagnosis	O
and	O
they	O
also	O
had	O
increased	O
risks	O
for	I:C1281905
incident	I:C1281905
vascular	O
diseases	I:C0042373
and	O
many	O
other	O
incident	O
comorbidities	O
after	O
the	O
diagnosis	O
compared	O
with	O
non-vasculitis	O
population	O
.	O

Patients	O
with	O
GCA	O
had	O
more	O
prior	O
vascular	O
diseases	I:C0042373
and	O
other	O
comorbidities	O
before	O
the	O
diagnosis	B:C0011900
and	O
they	O
also	O
had	O
increased	O
risks	O
for	I:C1281905
incident	I:C1281905
vascular	O
diseases	I:C0042373
and	O
many	O
other	O
incident	O
comorbidities	O
after	O
the	O
diagnosis	O
compared	O
with	O
non-vasculitis	O
population	O
.	O

Patients	O
with	O
GCA	O
had	O
more	O
prior	O
vascular	O
diseases	I:C0042373
and	O
other	O
comorbidities	O
before	O
the	O
diagnosis	O
and	O
they	O
also	O
had	O
increased	O
risks	B:C1281905
for	I:C1281905
incident	I:C1281905
vascular	O
diseases	I:C0042373
and	O
many	O
other	O
incident	O
comorbidities	O
after	O
the	O
diagnosis	O
compared	O
with	O
non-vasculitis	O
population	O
.	O

Patients	O
with	O
GCA	O
had	O
more	O
prior	O
vascular	O
diseases	I:C0042373
and	O
other	O
comorbidities	O
before	O
the	O
diagnosis	O
and	O
they	O
also	O
had	O
increased	O
risks	O
for	I:C1281905
incident	I:C1281905
vascular	B:C0042373
diseases	I:C0042373
and	O
many	O
other	O
incident	O
comorbidities	O
after	O
the	O
diagnosis	O
compared	O
with	O
non-vasculitis	O
population	O
.	O

Patients	O
with	O
GCA	O
had	O
more	O
prior	O
vascular	O
diseases	I:C0042373
and	O
other	O
comorbidities	O
before	O
the	O
diagnosis	O
and	O
they	O
also	O
had	O
increased	O
risks	O
for	I:C1281905
incident	I:C1281905
vascular	O
diseases	I:C0042373
and	O
many	O
other	O
incident	O
comorbidities	O
after	O
the	O
diagnosis	B:C0011900
compared	O
with	O
non-vasculitis	O
population	O
.	O

